Barclays PLC Assertio Holdings, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 6,395 shares of ASRT stock, worth $5,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,395
Previous 6,395
-0.0%
Holding current value
$5,179
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ASRT
# of Institutions
99Shares Held
29.5MCall Options Held
1.15MPut Options Held
121K-
Nantahala Capital Management, LLC New Canaan, CT8.15MShares$6.6 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.55 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.99MShares$2.42 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.12 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.1MShares$892,0350.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $39M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...